Responsiveness and minimal clinically important change in overactive bladder symptom score

Urology

Volumn 78, Issue 4, 2011, Pages 768-773

  Gotoh, Momokazu ^a   Homma, Yukio ^b   Yokoyama, Osamu ^c   Nishizawa, Osamu ^d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROPIVERINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DATA ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT CHANGE; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; OVERACTIVE BLADDER SYMPTOM SCORE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; URINARY URGENCY; URINE INCONTINENCE;

AGED; BENZILATES; CHOLINERGIC ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 80053894827     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.06.020     Document Type: Article

References (29)

1. P. Abrams, L. Cardozo, M. Fall Standardisation Sub-Committee of the International Continence Society The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society Urology 61 2003 37 49
2. P. Herbison, J. Hay-Smith, and G. Ellis Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review BMJ 326 2003 841 844
3. Y. Homma, J.S. Paick, J.G. Lee Japanese and Korean Tolterodine Study Group Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial BJU Int 92 2003 741 747
4. I. Milsom, P. Abrams, and L. Cardozo How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 2001 760 766
5. N.K. Leidy, D.A. Revicki, and B. Genesté Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value Health 2 1999 113 127
6. K. Coyne, D. Revicki, and T. Hunt Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q Qual Life Res 11 2002 563 574
7. L.S. Matza, C.L. Thompson, and J. Krasnow Testretest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ) Neurourol Urodyn 24 2005 215 225
8. Y. Homma, M. Yoshida, and N. Seki Symptom assessment tool for overactive bladder syndromeoveractive bladder symptom score Urology 68 2006 318 323
9. H. Kemmer, A.M. Mathes, and O. Dilk Obstructive sleep apnea syndrome is associated with overactive bladder and urgency incontinence in men Sleep 32 2009 271 275
10. L. Chih-Cheng Assessment of overactive bladder symptoms in a community-dwelling population using the Taiwanese version of the Overactive Bladder Symptom Score Incont Pelvic Floor Dysfunct 3 2009 60 61
11. L. Yi-Ting, and E. Chieh-Lung-Chou Assessment of overactive bladder (OAB)Symptom Scores Incont Pelvic Floor Dysfunct 3 suppl 1 2009 9 14
12. Y. Homma, and M. Gotoh Symptom severity and patient perceptions in overactive bladder: how are they related? BJU Int 104 2009 968 972
13. Y. Homma, H. Kakizaki, and O. Yamaguchi Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score Urology 77 2011 60 64
14. P. Fayers, and D. Machin Quality of Life 2nd ed. 2007 John Wiley & Sons West Sussex
15. D.A. Revicki, D. Osoba, and D. Fairclough Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Qual Life Res 9 2000 887 900
16. K.S. Coyne, A. Tubaro, and L. Brubaker Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts Urology 68 2006 9 16
17. M. Gotoh, O. Yokoyama, and O. Nishizawa Propiverine hydrochloride in Japanese patients with overactive bladder: a randomized, double-blind, placebo-controlled trial Int J Urol 18 2011 365 373
18. C.J. Kelleher, L.D. Cardozo, and V. Khullar A new questionnaire to assess the quality of life of urinary incontinent women Br J Obstet Gynaecol 104 1997 1374 1379
19. Y. Homma, M. Gotoh, and T. Ando Development of Japanese version of QOL questionnaires for urinary incontinence (in Japanese) J Neurogen Bladder Soc 10 1999 225 236
20. J. Cohen Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Lawrence Erlbaum Associates Philadelphia
21. E. Lydick, and R.S. Epstein Interpretation of quality of life changes Qual Life Res 2 1993 221 226
22. R.D. Hays, and J.M. Woolley The concept of clinically meaningful difference in health-related quality-of-life research How meaningful is it? Pharmacoeconomics 18 2000 419 423
23. H.C. de Vet, C.B. Terwee, and R.W. Ostelo Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change Health Qual Life Outcomes 4 2006 54
24. D.A. Revicki, D. Cella, and R.D. Hays Responsiveness and minimal important differences for patient reported outcomes Health Qual Life Outcomes 4 2006 70
25. D. Revicki, R.D. Hays, and D. Cella Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J Clin Epidemiol 61 2008 102 109
26. R.D. Crosby, R.L. Kolotkin, and G.R. Williams Defining clinically meaningful change in health-related quality of life J Clin Epidemiol 56 2003 395 407
27. W.J. Youden Index for rating diagnostic tests Cancer 3 1950 32 35
28. Y. Homma, H. Kakizaki, and M. Gotoh Epidemiologic survey on lower urinary tract symptoms in Japan Jpn J Neurogenic Bladder Soc 14 2003 266 277
29. Third International Consultation On Incontinence http://www.icsoffice. org/Publications/ICI-3/v1.pdf/chap10.pdf Accessed July 21, 2011